Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cinzia Scandellari

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Artificial Intelligence in Medicine|May 29, 2002
An expert system for the evaluation of EDSS in multiple sclerosisMauro Gaspari, Gianluigi Roveda, Cinzia Scandellari, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|March 11, 2009
Refining an automatic EDSS scoring expert system for routine clinical use in multiple sclerosisMauro Gaspari, Davide Saletti, Cinzia Scandellari, et al.
Multiple Sclerosis and Related Disorders|July 9, 2018
Teeth loss after teriflunomide treatment: Casual or causal? A short case seriesVeria Vacchiano, Nicola Frattaruolo, Luca Mancinelli, et al.
Frontiers in Neurology|April 14, 2022
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic SurveySusan Mohamed, Giovanna Lopane, Loredana Sabattini, et al.
Clinical Neuropharmacology|July 20, 2018
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect RelationshipManuela Contin, Luca Mancinelli, Alessandro Perrone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study resultsRuggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Journal of Neurology|February 5, 2013
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective studyRoberto D'Alessandro, Luca Vignatelli, Alessandra Lugaresi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 27, 2018
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosisElisa Baldin, Trond Riise, Katia Mattarozzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Mauro Zaffaroni, Lucia Moiola, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Artificial Intelligence in Medicine|May 29, 2002
An expert system for the evaluation of EDSS in multiple sclerosisMauro Gaspari, Gianluigi Roveda, Cinzia Scandellari, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|March 11, 2009
Refining an automatic EDSS scoring expert system for routine clinical use in multiple sclerosisMauro Gaspari, Davide Saletti, Cinzia Scandellari, et al.
Multiple Sclerosis and Related Disorders|July 9, 2018
Teeth loss after teriflunomide treatment: Casual or causal? A short case seriesVeria Vacchiano, Nicola Frattaruolo, Luca Mancinelli, et al.
Frontiers in Neurology|April 14, 2022
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic SurveySusan Mohamed, Giovanna Lopane, Loredana Sabattini, et al.
Clinical Neuropharmacology|July 20, 2018
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect RelationshipManuela Contin, Luca Mancinelli, Alessandro Perrone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study resultsRuggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Journal of Neurology|February 5, 2013
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective studyRoberto D'Alessandro, Luca Vignatelli, Alessandra Lugaresi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 27, 2018
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosisElisa Baldin, Trond Riise, Katia Mattarozzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Mauro Zaffaroni, Lucia Moiola, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Pageof 2